Vanderbilt's Early Psychosis Program - Vanderbilt University — Nashville, Tennessee

Vanderbilt's Early Psychosis Program - Vanderbilt University is a clinical research site located in Nashville, Tennessee, United States 37212.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt's Early Psychosis Program - Vanderbilt University has participated in 1 clinical trials.

Therapeutic areas: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders.

Sponsors: Indiana University.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt's Early Psychosis Program - Vanderbilt University?

Vanderbilt's Early Psychosis Program - Vanderbilt University has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt's Early Psychosis Program - Vanderbilt University conducted?

Vanderbilt's Early Psychosis Program - Vanderbilt University has 1 clinical trials on record. Their work covers Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders.

Is Vanderbilt's Early Psychosis Program - Vanderbilt University accredited by Crixeo Health?

Vanderbilt's Early Psychosis Program - Vanderbilt University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt's Early Psychosis Program - Vanderbilt University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.